Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux

被引:128
作者
Honda, Y
Ushigome, F
Koyabu, N
Morimoto, S
Shoyama, Y
Uchiumi, T
Kuwano, M
Ohtani, H
Sawada, Y
机构
[1] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Medicopharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan
[2] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Chemopharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan
[3] Kyushu Univ, Grad Sch Med Sci, Dept Biochem Med, Higashi Ku, Fukuoka 8128582, Japan
[4] Kurume Univ, Res Ctr Innovat Canc Therapy, 21st Century COE Program Med Sci, Fukuoka 8300011, Japan
关键词
P-glycoprotein; MDR1; MRP2; transport; grapefruit juice; orange juice; furanocoumarins; polymethoxyflavones; vinblastine; saquinavir;
D O I
10.1038/sj.bjp.0706008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We investigated the effects of grapefruit juice (GFJ) and orange juice (OJ) on drug transport by MDR1 P-glycoprotein (P-gp) and multidrug resistance protein 2 (MRP2), which are efflux transporters expressed in human small intestine. 2 We examined the transcellular transport and uptake of [H-3]vinblastine (VBL) and [C-14]saquinavir in a human colon carcinoma cell line (Caco-2) and in porcine kidney epithelial cell lines transfected with human MDR1 cDNA and human MRP2 cDNA, LLC-GA5-COL150, and LLC-MRP2, respectively. 3 In Caco-2 cells, the basal-to-apical transports of [H-3]VBL and [C-14] saquinavir were greater than those in the opposite direction. The ratio of basal-to-apical transport to apical-to-basal transport of [H-3]VBL and [C-14]saquinavir by Caco-2 cells was reduced in the presence of MK571 (MRPs inhibitor), verapamil (P-gp inhibitor), cyclosporin A (inhibitor of both), 50% ethyl acetate extracts of GFJ and OJ, or their components (6',7'-dihydroxybergamottin, bergamottin, tangeretin, hepatomethoxyflavone, and nobiletin). 4 Studies of transport and uptake of [H-3]VBL and [C-14]saquinavir with MDR1 and MRP2 transfectants showed that VBL and saquinavir are transported by both P-gp and MRP2. GFJ and OJ components inhibited the transport by MRP2 as well as P-gp. However, their inhibitory potencies for P-gp or MRP2 were substrate-dependent. 5 The present study has revealed that GFJ and OJ interact with not only P-gp but also MRP2, both of which are expressed at apical membranes and limit the apical-to-basal transport of VBL and saquinavir in Caco-2 cells.
引用
收藏
页码:856 / 864
页数:9
相关论文
共 29 条
  • [1] INTERACTION OF CITRUS JUICES WITH FELODIPINE AND NIFEDIPINE
    BAILEY, DG
    SPENCE, JD
    MUNOZ, C
    ARNOLD, JMO
    [J]. LANCET, 1991, 337 (8736) : 268 - 269
  • [2] Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells
    Bock, KW
    Eckle, T
    Ouzzine, M
    Fournel-Gigleux, S
    [J]. BIOCHEMICAL PHARMACOLOGY, 2000, 59 (05) : 467 - 470
  • [3] A family of drug transporters: The multidrug resistance-associated proteins
    Borst, P
    Evers, R
    Kool, M
    Wijnholds, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16): : 1295 - 1302
  • [4] EXPRESSION OF THE MULTIDRUG RESISTANCE GENE-PRODUCT (P-GLYCOPROTEIN) IN HUMAN NORMAL AND TUMOR-TISSUES
    CORDONCARDO, C
    OBRIEN, JP
    BOCCIA, J
    CASALS, D
    BERTINO, JR
    MELAMED, MR
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (09) : 1277 - 1287
  • [5] Döppenschmitt S, 1999, J PHARMACOL EXP THER, V288, P348
  • [6] Eagling VA, 1999, BRIT J CLIN PHARMACO, V48, P543, DOI 10.1046/j.1365-2125.1999.00052.x
  • [7] Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA
    Evers, R
    Kool, M
    van Deemter, L
    Janssen, H
    Calafat, J
    Oomen, LCJM
    Paulusma, CC
    Elferink, RPJO
    Baas, F
    Schinkel, AH
    Borsi, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (07) : 1310 - 1319
  • [8] THE LEUKOTRIENE LTD(4) RECEPTOR ANTAGONIST MK571 SPECIFICALLY MODULATES MRP ASSOCIATED MULTIDRUG-RESISTANCE
    GEKELER, V
    ISE, W
    SANDERS, KH
    ULRICH, WR
    BECK, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 208 (01) : 345 - 352
  • [9] GUENGERICH FP, 1990, CARCINOGENESIS, V11, P2275, DOI 10.1093/carcin/11.12.2275
  • [10] Interactions of HIV protease inhibitors with ATP-dependent drug export proteins
    Gutmann, H
    Fricker, G
    Drewe, J
    Toeroek, M
    Miller, DS
    [J]. MOLECULAR PHARMACOLOGY, 1999, 56 (02) : 383 - 389